Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news ...

PeaceHealth's move to replace ER doctors with ApolloMD clinicians is testing a new state law limiting corporate medicine.

Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

With the drop in overdose deaths, “we're celebrating: a death toll that exceeds total American combat fatalities in Vietnam, ...

The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more ...

Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.

United Health Services, a behavioral health provider that operates over 340 inpatient facilities across 40 states, announced Monday that it will acquire ...

There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public ...

Fresh turmoil at the FDA with Prasad’s exit. Vinay Prasad is out at the Food and Drug Administration for the second time during the Trump administration, after a tumultuous reig ...

Vinay Prasad's unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his ...

A federal advisory committee on autism issues has canceled plans for its first public meeting since new members were ...

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.